IGF1R Knockout HEK293 Cell Line
Cat.No.:
EDC90491
Species:
Human
Cell Name:
HEK293
Gene:
IGF1R
Gene ID:
3480
Size:
1×10⁶cells
IGF1R Knockout HEK293 Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC90491 |
|---|---|
| Product Name | IGF1R Knockout HEK293 Cell Line |
| Species | Human |
| Cell Line | HEK293 |
| Cellosaurus ID | CVCL_0045 |
| Gene ID | |
| Cell Line Synonyms | Hek293, HEK-293, HEK/293, (HEK)293, HEK 293, HEK,293, 293, 293 HEK, 293 Ad5, Graham 293, Graham-293, Human Embryonic Kidney 293 |
| Gene | IGF1R |
| Gene Synonyms | CD221|IGFIR|IGFR|JTK13 |
| Summary |
This receptor binds insulin-like growth factor with a high affinity. It has tyrosine kinase activity. The insulin-like growth factor I receptor plays a critical role in transformation events. Cleavage of the precursor generates alpha and beta subunits. It is highly overexpressed in most malignant tissues where it functions as an anti-apoptotic agent by enhancing cell survival. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, May 2014]
|
| Associated Diseases | Non-tumor |
| Digestion Time | / |
| Morphology | Semi-Suspension, Semi-Adherent |
| Passage Ratio | 1:5 |
| Complete Culture Medium | DMEM+10% FBS |
| Freezing Medium | 95% complete culture medium + 5% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HEK293 | STR Info (Cell bank) Cell Line: HEK293 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1P0 | 12 | 11 | 12 | |
| D2S1338 | 19 | 19 | ||
| D3S1358 | 15 | 17 | 15 | 17 |
| D5S818 | 8 | 8 | 9 | |
| D7S820 | 11 | 12 | 11 | 12 |
| D8S1179 | 12 | 14 | 12 | 14 |
| D13S317 | 12 | 14 | 12 | 14 |
| D16S539 | 9 | 13 | 9 | 13 |
| D18S51 | 17 | 18 | 17 | 18 |
| D19S433 | 15 | 18 | 15 | 18 |
| D21S11 | 28 | 30.2 | 28 | 30.2 |
| FGA | 23 | 23 | ||
| Penta D | 9 | 10 | 9 | 10 |
| Penta E | 7 | 15 | 7 | 15 |
| TH01 | 7 | 9.3 | 7 | 9.3 |
| TPOX | 11 | 11 | ||
| vWA | 16 | 19 | 16 | 19 |
| D6S1043 | 11 | 11 | ||
| D12S391 | 19 | 21 | 11 | 15 |
| D2S441 | 11 | 15 | 11 | 15 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying IGF1R function, IGF1R Knockout HEK293 Cell Line or IGF1R overexpression HEK293 Cell Line?
The choice depends on whether you are studying IGF1R (insulin-like growth factor 1 receptor)'s role as the principal IGF-1/IGF-2 receptor tyrosine kinase or its functions in cancer cell proliferation and survival. The Knockout line is the standard tool for asking whether IGF1R is required for these processes — IGF1R is a receptor tyrosine kinase structurally similar to INSR (α2β2 tetramer), binding IGF-1 with high affinity and IGF-2 with moderate affinity, autophosphorylating and recruiting IRS1/IRS2 to drive PI3K-AKT and MAPK signaling. Overexpression is useful for studying IGF1R gain-of-function effects in cancer.
For cancer biology research, the EDITGENE IGF1R Knockout in HEK293 is a workhorse mechanistic platform — HEK293 supports systematic structure-function studies. INSR paralog expression analysis is essential — INSR and IGF1R can form heterodimers (insulin/IGF hybrid receptors). This product complements the parallel IGF1R Knockout in A-549 (also available); HEK293 is preferred for biochemistry, A-549 for lung cancer context. Rescue with wild-type or kinase-dead IGF1R is the standard specificity control. The knockout is a critical specificity tool for IGF1R inhibitors (linsitinib/OSI-906, picropodophyllin/AXL1717, BMS-754807, ceritinib) and anti-IGF1R antibodies (figitumumab, ganitumab, dalotuzumab) in cancer drug development.
What are the application scenarios for this model?
Primary applications:
• IGF-1/IGF-2 binding and signaling: phospho-IGF1R (Y1135/Y1136), phospho-IRS1, and phospho-AKT analysis following IGF-1 or IGF-2 stimulation in IGF1R-null cells.
• INSR/IGF1R hybrid receptor analysis: IGF1R-INSR heterodimer formation analysis (insulin/IGF hybrid receptors) in the absence of IGF1R homodimers.
• IGF1R inhibitor specificity: critical genetic control for linsitinib (OSI-906), BMS-754807, picropodophyllin, and other IGF1R-targeting tyrosine kinase inhibitors.
• Anti-IGF1R antibody specificity: figitumumab, ganitumab, dalotuzumab antibody specificity testing.
EDITGENE recommends this HEK293-based model for biochemical IGF1R research and structure-function studies; the parallel IGF1R Knockout in A-549 is preferred for lung cancer-relevant studies.
Is this IGF1R Knockout HEK293 Cell Line compatible with overexpression rescue experiments?
Yes. IGF1R rescue experiments are well-established for RTK research:
• Construct design: use a codon-modified IGF1R sequence with a small intracellular C-terminal tag (FLAG, HA). IGF1R is processed from a single precursor into α and β chains (α2β2 tetramer) — preserve processing and membrane topology.
• Surface localization validation: confirm plasma membrane α2β2 tetramer expression before functional assays.
• Kinase-dead rescue: K1003A in the ATP-binding lysine abolishes catalytic activity.
• INSR partnership: IGF1R-INSR heterodimer formation in cells expressing both receptors — rescue interpretation considers INSR levels.
• Functional readout: rescue should restore IGF-1-induced phospho-IGF1R, IRS1 phosphorylation, and PI3K-AKT signaling.
HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
Related Publications
Bovine respiratory syncytial virus utilizes the human insulin-like growth factor 1 receptor in the late stages of infection.
IF=4.3
The Journal of general virology
Bovine respiratory syncytial virus (BRSV) is a major viral pathogen associated with the bovine respiratory disease complex, which is a leading cause of morbidity, mortality and economic loss in the cattle industry worldwide. Clinical infection is most severe in young calves, where it commonly causes lower respiratory tract inflammation, bronchopneumonia and predisposition to secondary bacterial infections. In experimental research, BRSV is typically maintained in Vero and MDBK cells. Although reverse genetics systems have been established for BRSV, we developed a bacterial artificial chromosome-based reverse genetics system for the virus. We successfully recovered a recombinant BRSV with the ZsGreen reporter gene inserted between the P and M genes. The recombinant virus displayed comparable growth kinetics to the WT strain, demonstrating the utility of the system for generating reporter viruses. Reporter virus infectivity assessments in mammalian MDBK, VeroE6, HEp-2 and HEK293T cells revealed that HEK293T cells are permissive to BRSV. To investigate the potential role of human insulin-like growth factor 1 receptor (hIGF1R), which human RSV uses for entry, we infected insulin-like growth factor 1 receptor (IGF1R)-knockout (KO) 293 T cells with BRSV-ZsGreen. At 24 h post-infection (hpi), ZsGreen levels were similar between WT and hIGF1R-KO cells; however, by 72 hpi, viral spread was markedly reduced in hIGF1R-KO cells and correlated with IGF1R levels. These findings suggest that IGF1R is dispensable for early BRSV infection but contributes to efficient viral propagation in later stages.
This KO model may be useful for:
- Investigating the role of IGF1R in late-stage viral propagation and cell-to-cell spread of paramyxoviruses like bovine respiratory syncytial virus
- Studying host factors that modulate viral replication kinetics independently of initial entry mechanisms
- Examining IGF1R-dependent processes in respiratory virus-induced cytopathology and syncytium formation
- Analyzing the differential contribution of IGF1R to early versus late infection phases in human cell lines
- Validating reporter virus systems for tracking viral spread in IGF1R-deficient backgrounds
download